Literature DB >> 17287038

The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II study.

Jerzy Wydmański1, Rafal Suwinski, Stanislaw Poltorak, Bogusław Maka, Leszek Miszczyk, Edyta Wolny, Grzegorz Bielaczyc, Aleksander Zajusz.   

Abstract

The aim of study was to assess the tolerance and effectiveness of preoperative chemoradiotherapy in the group of 40 patients with operable gastric cancer. The therapy was well tolerated. We observed the high rate of pathological response and R0 resections, low rate of local recurrence and high percent of 2-year survival.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17287038     DOI： 10.1016/j.radonc.2007.01.009

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  15 in total

1.  A decade in gastric cancer curative surgery: Evidence of progress (1999-2009).

Authors:  Stefano Rausei; Gianlorenzo Dionigi; Francesca Rovera; Luigi Boni; Caterina Valerii; Luisa Giavarini; Francesco Frattini; Renzo Dionigi
Journal:  World J Gastrointest Surg       Date:  2012-03-27

Review 2.  Neoadjuvant therapy for gastric cancer: current evidence and future directions.

Authors:  Andrew D Newton; Jashodeep Datta; Arturo Loaiza-Bonilla; Giorgos C Karakousis; Robert E Roses
Journal:  J Gastrointest Oncol       Date:  2015-10

3.  Influence of interfraction motion on margins for radiotherapy of gastric cancer.

Authors:  A Namysł-Kaletka; J Wydmanski; A Tukiendorf; D Bodusz; W Leszczynski; R Kawczynski; K Grabinska; P Polanowski
Journal:  Br J Radiol       Date:  2015-02-10       Impact factor: 3.039

4.  Protection of organs at risk during neoadjuvant chemoradiotherapy for gastric cancer based on a comparison between conformal and intensity-modulated radiation therapy.

Authors:  Leszek Hawrylewicz; Wojciech Leszczyński; Agnieszka Namysł-Kaletka; Iwona Bronclik; Jerzy Wydmański
Journal:  Oncol Lett       Date:  2016-05-26       Impact factor: 2.967

5.  Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.

Authors:  Mi Sun Kim; Joon Seok Lim; Woo Jin Hyung; Yong Chan Lee; Sun Young Rha; Ki Chang Keum; Woong Sub Koom
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

6.  Radiotherapy and chemoradiotherapy as a novel option for the treatment of locally advanced inoperable gastric adenocarcinoma: A phase II study.

Authors:  Jerzy Wydmanski; Kinga Grabinska; Pawel Polanowski; Agnieszka Namysl-Kaletka; Rafal Kawczynski; Malgorzata Kraszkiewicz; Wojciech Majewski
Journal:  Mol Clin Oncol       Date:  2014-07-11

Review 7.  Management strategies for locoregional recurrence in early-stage gastric cancer: retrospective analysis and comprehensive literature review.

Authors:  Ahmed Salem; Sameh Hashem; Layth Y I Mula-Hussain; Issa Mohammed; Ala'a Nour; Wael Shelpai; Faiez Daoud; Basem Morcos; Yasser Yamin; Imad Jaradat; Jamal Khader; Abdelatief Almousa
Journal:  J Gastrointest Cancer       Date:  2012-03

8.  Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery.

Authors:  Milan Vošmik; Jan Laco; Igor Sirák; Josef Dvořák; Petr Lochman; Miroslav Hodek; Petra Malá; Stanislav Rejchrt; Rudolf Repák; Michal Leško; Alexander Ferko; Aleš Ryška; Bohuslav Melichar; Jiří Petera
Journal:  Pathol Oncol Res       Date:  2017-05-27       Impact factor: 3.201

9.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

10.  Benefits and challenges of radiation therapy in gastric cancer: techniques for improving outcomes.

Authors:  Susan A McCloskey; Gary Y Yang
Journal:  Gastrointest Cancer Res       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.